Westhampton Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Westhampton Capital’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$939K	Hold	1,238	–	–	0.42%	64
2026 Q2	$772K	Buy	1,238 +15	+1%	+$10.2K	0.32%	74
2026 Q1	$945K	Hold	1,223	–	–	0.44%	64
2025 Q4	$944K	Buy	1,223 +40	+3%	+$27.2K	0.45%	65
2025 Q3	$665K	Buy	1,183 +56	+5%	+$31.7K	0.32%	76
2025 Q2	$592K	Buy	1,127 +42	+4%	+$23.4K	0.31%	80
2025 Q1	$688K	Buy	1,085 +22	+2%	+$15.1K	0.38%	75
2024 Q4	$757K	Buy	1,063 +170	+19%	+$143K	0.39%	72
2024 Q3	$939K	Buy	893 +15	+2%	+$16.7K	0.48%	66
2024 Q2	$923K	Hold	878	–	–	0.5%	62
2024 Q1	$845K	Buy	878 +15	+2%	+$14.3K	0.46%	67
2023 Q4	$758K	Hold	863	–	–	0.45%	66
2023 Q3	$710K	Hold	863	–	–	0.46%	69
2023 Q2	$620K	Buy	863 +20	+2%	+$15.4K	0.4%	68
2023 Q1	$693K	Hold	843	–	–	0.44%	68
2022 Q4	$608K	Buy	843 +22	+3%	+$16.2K	0.41%	71
2022 Q3	$566K	Hold	821	–	–	0.43%	72
2022 Q2	$485K	Buy	821 +3	+0.4%	+$1.95K	0.34%	84
2022 Q1	$571K	Hold	818	–	–	0.37%	77
2021 Q4	$517K	Hold	818	–	–	0.32%	83
2021 Q3	$495K	Hold	818	–	–	0.34%	82
2021 Q2	$457K	Buy	818 +20	+3%	+$10.1K	0.3%	86
2021 Q1	$378K	Buy	798 +24	+3%	+$11.7K	0.26%	87
2020 Q4	$374K	Hold	774	–	–	0.28%	81
2020 Q3	$433K	Buy	774 +24	+3%	+$14.6K	0.35%	80
2020 Q2	$468K	Hold	750	–	–	0.41%	67
2020 Q1	$366K	Hold	750	–	–	0.38%	70
2019 Q4	$282K	Hold	750	–	–	0.23%	91
2019 Q3	$208K	Buy	+750	New	+$222K	0.17%	106

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.22B AUM 4.07% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Westhampton Capital's REGN Position: Q3 2026 in Review

Westhampton Capital held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 1,238 shares worth $939K. The position accounts for 0.42% of the portfolio, ranked #64.

Westhampton Capital first reported a position in REGN in Q3 2019 and has held it in 29 quarters since. The position peaked at $945K in Q1 2026. 611 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

Westhampton Capital held 1,238 shares of Regeneron Pharmaceuticals worth $939K as of Q3 2026.
Westhampton Capital left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
Regeneron Pharmaceuticals made up 0.42% of Westhampton Capital's portfolio in Q3 2026, its #64 holding.
Westhampton Capital first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 29 quarters since.
Westhampton Capital's Regeneron Pharmaceuticals position peaked at $945K in Q1 2026.
611 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Westhampton Capital's 13F filing for Q3 2026, filed 30 Oct 2026.